<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0376505</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6793</journal-id>
<journal-id journal-id-type="nlm-ta">Psychosom Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Psychosom Med</journal-id>
<journal-title-group>
<journal-title>Psychosomatic medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0033-3174</issn>
<issn pub-type="epub">1534-7796</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26489030</article-id>
<article-id pub-id-type="pmc">4643359</article-id>
<article-id pub-id-type="doi">10.1097/PSY.0000000000000242</article-id>
<article-id pub-id-type="manuscript">NIHMS715922</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic predictors of depressive symptoms in the Look AHEAD Trial</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>McCaffery</surname>
<given-names>Jeanne M.</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A1">Weight Control and Diabetes Research Center, The Miriam Hospital and Warren Alpert School of Medicine at Brown University, Providence, RI, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Papandonatos</surname>
<given-names>George D.</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A2">Center for Statistical Sciences, Brown University, Providence, RI, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Faulconbridge</surname>
<given-names>Lucy F.</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A3">Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Erar</surname>
<given-names>Bahar</given-names>
</name>
<degrees>M.Sc.</degrees>
<aff id="A4">Center for Statistical Sciences, Brown University, Providence, RI, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peter</surname>
<given-names>Inga</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A5">Department of Genetics &amp; Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wagenknecht</surname>
<given-names>Lynne E.</given-names>
</name>
<degrees>Dr.P.H.</degrees>
<aff id="A6">Look AHEAD Coordinating Center, Division of Public Health Sciences, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pajewski</surname>
<given-names>Nicholas M.</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A7">Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>Andrea</given-names>
</name>
<degrees>M.S.</degrees>
<aff id="A8">Look AHEAD Coordinating Center, Division of Public Health Sciences, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wadden</surname>
<given-names>Thomas A.</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A9">Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wing</surname>
<given-names>Rena R.</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A10">Weight Control and Diabetes Research Center, The Miriam Hospital and Warren Alpert School of Medicine at Brown University, Providence, RI, USA</aff>
</contrib>
<contrib contrib-type="author">
<collab>The Look AHEAD Research Group</collab>
</contrib>
</contrib-group>
<author-notes>
<corresp id="FN1">Corresponding Author: Jeanne McCaffery, PhD, Associate Professor, Weight Control and Diabetes Research Center, The Miriam Hospital and Brown Medical School, 196 Richmond Street, Providence, R.I. 02903, Phone: 401 793-8010, Fax: 401 793-8944, <email>jeanne_mccaffery@brown.edu</email></corresp>
<fn fn-type="conflict" id="FN5">
<p><underline>Conflicts of interest:</underline> None</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<season>Nov-Dec</season>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2016</year>
</pub-date>
<volume>77</volume>
<issue>9</issue>
<fpage>982</fpage>
<lpage>992</lpage>
<!--elocation-id from pubmed: 10.1097/PSY.0000000000000242-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">Numerous studies find elevated depressive symptoms among individuals with type 2 diabetes, yet the mechanisms remain unclear. We examined whether genetic loci previously associated with depressive symptoms predict depressive symptoms among overweight/obese individuals with type 2 diabetes or change in depressive symptoms during behavioral weight loss.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">The <italic>Illumina CARe iSelect</italic> (IBC) chip and Cardiometabochip were characterized in 2,118 overweight or obese participants with type 2 diabetes from Look AHEAD (Action for Health in Diabetes), a randomized trial to determine the effects of intensive lifestyle intervention (ILI) and Diabetes Support and Education (DSE) on cardiovascular morbidity and mortality. Primary analyses focused on baseline Beck Depression Inventory (BDI) scores and depressive symptom change at one year.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Of eight single nucleotide polymorphisms (SNPs) in six loci, three <italic>a priori</italic> SNPs in two loci (Chr5: rs60271; <italic>LBR:</italic> rs2230419, rs1011319) were associated with baseline BDI scores, but in the opposite direction of prior research. In joint analysis of 90,003 IBC and Cardiometabochip SNPs, rs1543654 in the region of <italic>KCNE1</italic> predicted change in BDI scores at year 1 in DSE (beta= −1.05, SE=0.21, <italic>p</italic>=6.9 × 10<sup>−7</sup>) at the level of chip-wide significance, while also showing a nominal association with baseline BDI (beta=0.35, SE=0.16, <italic>p</italic>=0.026). Adjustment for antidepressant medication and/or limiting analyses to Non-Hispanic White individuals did not meaningfully alter results.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">Previously reported genetic associations with depressive symptoms did not replicate in this cohort of overweight/obese individuals with type 2 diabetes. We identified <italic>KCNE1</italic> as a potential novel locus associated with depressive symptoms.</p>
</sec>
</abstract>
<kwd-group>
<kwd>genetics</kwd>
<kwd>depression</kwd>
<kwd>diabetes</kwd>
<kwd>weight loss</kwd>
<kwd>obesity</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>